Cancer Progress and Priorities: Prostate Cancer

Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):267-277. doi: 10.1158/1055-9965.EPI-19-0412.

Authors

Kevin H Kensler¹, Timothy R Rebbeck²

Affiliations

¹ Division of Population Sciences, Dana-Farber Cancer Institute and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
² Division of Population Sciences, Dana-Farber Cancer Institute and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. timothy_rebbeck@dfci.harvard.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Global Burden of Disease*
Humans
Incidence
Male
Mass Screening / organization & administration
Mortality / trends
Prostate / pathology
Prostatic Intraepithelial Neoplasia / diagnosis
Prostatic Intraepithelial Neoplasia / epidemiology*
Prostatic Intraepithelial Neoplasia / pathology
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / epidemiology*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / prevention & control
Risk Assessment / methods
Risk Factors

Grants and funding